211 – 220 of 335
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
(
- Contribution to journal › Article
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The endocytic pathway in microglia during health, aging and Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Socioeconomic Predictors of the Employment of Migrant Care Workers by Italian Families Assisting Older Alzheimer's Disease Patients : Evidence from the Up-Tech Study
2016) In Journals of Gerontology - Series B Psychological Sciences and Social Sciences 71(3). p.514-525(
- Contribution to journal › Article
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article
- 2015
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
(
- Contribution to journal › Article
-
Mark
The economic impact of moderate stage Alzheimer's disease in Italy : Evidence from the UP-TECH randomized trial
(
- Contribution to journal › Article